Hipolip en es it fr

Hipolip Brand names, Hipolip Analogs

Hipolip Brand Names Mixture

  • No information avaliable

Hipolip Chemical_Formula

C24H36O5

Hipolip RX_link

http://www.rxlist.com/cgi/generic3/altocor.htm

Hipolip fda sheet

Hipolip FDA

Hipolip msds (material safety sheet)

Hipolip Synthesis Reference

R. L. Monaghan et al., U.S. Pat. 4,231,938 (1980)

Hipolip Molecular Weight

404.54 g/mol

Hipolip Melting Point

174.5 oC

Hipolip H2O Solubility

0.0004 mg/mL

Hipolip State

Solid

Hipolip LogP

4

Hipolip Dosage Forms

Tablet

Hipolip Indication

For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia; For primary prevention of coronary heart disease

Hipolip Pharmacology

Lovastatin, an antilipemic agent produced by fermentation of Aspergillus terreus, is the first of a class of lipid-lowering agents known as the HMG-CoA reductase inhibitors. Lovastatin is used to treat hypercholesterolemia, to slow coronary atherosclerosis, and to prevent myocardial infarction and stroke. Lovastatin, like simvastin and unlike pravastatin, is a prodrug, concentrating active drug in the liver during first-pass circulation.

Hipolip Absorption

30%

Hipolip side effects and Toxicity

LD50>1000 mg/kg (orally in mice)

Hipolip Patient Information

PATIENT INFORMATION

Lovastatin is used to lower high cholesterol levels. This medication should
not be taken if you are pregnant, nursing, or have liver disease. Lovastatin
should be taken with the evening meal. This medication may cause increased
sensitivity to sunlight. Use sunscreens and wear protective clothing until
degree of sensitivity is determined. Notify your physician if you develop
blurred vision; skin rash; muscle pain, weakness, or cramps; unexplained fever,
or yellowing of the skin or eyes.

Patients should be advised about substances they should not take concomitantly
with lovastatin and be advised to report promptly unexplained muscle pain,
tenderness, or weakness (see list below and WARNINGS, Myopathy/Rhabdomyolysis ).
Patients should also be advised to inform other physicians prescribing a new
medication that they are taking MEVACOR .

Hipolip Organisms Affected

Humans and other mammals